126
Participants
Start Date
August 29, 2017
Primary Completion Date
December 31, 2023
Study Completion Date
June 30, 2027
Revivent TC
Treatment of LV scar
Mount Sinai Hospital, New York
New York Presbyterian Hospital, New York
Penn State Health Milton S. Hershey Medical Center, Hershey
UPMC Pinnacle, Harrisburg
Hospital of the University of Pennsylvania, Philadelphia
Winchester Medical Center, Winchester
Wake Forest Baptist Hospital, Winston-Salem
Medical University of South Carolina, Charleston
WellStar Health System, Marietta
Emory University Hospital Midtown, Atlanta
Baptist Hospital of Maimi, Miami
Cleveland Clinic, Cleveland
University of Minnesota Medical Center, Minneapolis
Memorial Medical Center, Springfield
Saint Luke's Hospital of Kansas City, Kansas City
Terrebonne General Medical Center, Houma
Oklahoma Heart Hospital, Oklahoma City
CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston
Houston Methodist Hospital, Houston
University of Arizona College of Medicine - Phoenix Banner University Medicine Heart Institute, Phoenix
Ronald Regan UCLA Medical Center, Los Angeles
Los Robles Hospital & Medical Center, Thousand Oaks
University of California, San Francisco, San Francisco
University of Michigan, Ann Arbor
Hackensack University Medical Center, Hackensack
Nemocnice Na Homolce, Prague
Hygeia Hospital, Athens
Interbalkan Medical Center, Thessaloniki
Papworth Hospital NHS Foundation Trust, Cambridge
Freeman Hospital, Newcastle upon Tyne
Lead Sponsor
BioVentrix
INDUSTRY